Yes, generic versions of Januvia (sitagliptin) are now FDA-approved and entering the U.S. market. The first generic was approved on December 30, 2025, with additional manufacturers receiving approval in January 2026. This is a significant development for the roughly millions of Americans who take this type 2 diabetes medication, since brand-name Januvia costs around $350 for a 30-day supply without insurance.
Which Generic Versions Are Available
Multiple pharmaceutical companies have received FDA approval to manufacture generic sitagliptin phosphate tablets. Watson Laboratories received the first approval in late December 2025. Sandoz received approval on January 14, 2026, and Apotex followed on January 20, 2026. All three strengths of the original Januvia (25 mg, 50 mg, and 100 mg) are covered by these approvals.
There is also an authorized generic called Zituvio, manufactured by Zydus Pharmaceuticals. An authorized generic is essentially the same pill as the brand name, produced under agreement with the original manufacturer, Merck. It’s worth noting that FDA approval doesn’t always mean a drug is immediately sitting on pharmacy shelves. Availability can lag behind the approval date, so you may need to ask your pharmacist when a specific generic version is in stock.
What About Janumet?
If you take Janumet, the combination pill that contains both sitagliptin and metformin, the situation is different. There is currently no generic version of Janumet available in the United States. Multiple generic manufacturers are expected to bring their versions to market in May 2026. In the meantime, you could ask your doctor about taking generic sitagliptin alongside generic metformin (which has been available for years) as separate pills to reduce costs.
How Much You Can Expect to Save
Brand-name Januvia runs about $350 per month without insurance. Generic versions of most medications typically cost 30% to 80% less than the brand name, though exact pricing for generic sitagliptin will depend on your pharmacy, your location, and how many manufacturers are actively competing in the market.
If you’re on Medicare Part D, costs work a bit differently. Once you meet your plan’s annual deductible (up to $590 in 2025 or $615 in 2026), you pay 25% of the drug’s cost. Once your total out-of-pocket spending hits $2,000 in 2025 ($2,100 in 2026), you pay nothing for prescriptions the rest of the year. Generics count the same as brand-name drugs in this calculation, but because the price is lower, your 25% share will be smaller. Medicare has also renegotiated the list price of Januvia itself for 2026, bringing the brand-name cost for Medicare enrollees down to $113 for a 30-day supply.
How Sitagliptin Works
Sitagliptin belongs to a class of drugs called DPP-4 inhibitors. After you eat, your gut releases hormones called incretins that signal your pancreas to produce insulin. Normally, an enzyme called DPP-4 breaks down these hormones within minutes. Sitagliptin blocks that enzyme, letting the incretins stick around longer and do their job more effectively. The result is that your pancreas releases more insulin when your blood sugar is high, and your liver dials back on releasing stored sugar.
This mechanism is relatively targeted. Because it only amplifies insulin release in response to meals (rather than forcing constant insulin production), sitagliptin carries a lower risk of causing dangerously low blood sugar compared to some older diabetes medications. The generic versions contain the same active ingredient and work the same way. The FDA requires generic drugs to demonstrate bioequivalence, meaning they deliver the same amount of medication into your bloodstream at the same rate as the brand name.
Switching From Brand to Generic
If you’re currently taking Januvia, switching to generic sitagliptin is straightforward. Your pharmacist may automatically substitute the generic when filling your prescription, depending on your state’s pharmacy laws and your doctor’s instructions. You don’t need a new prescription in most cases.
Check with your insurance plan about formulary placement. Some insurers move quickly to prefer generics over brand-name drugs, which means the generic could land on a lower cost tier than Januvia. Others take a few months to update their formularies. If your plan still lists only brand-name Januvia, calling your insurer or asking your pharmacist to run the generic through your insurance can clarify what you’ll actually pay. Your doctor can also write “dispense as written” if for any reason you need to stay on the brand, though this is rarely necessary with FDA-approved generics.